Cargando…
Pharmacogenomics of antidepressant treatment effects
There has been considerable promise and hope that pharmacogenomics will optimize existing treatments for major depression, as well as identify novel targets for drug discovery. Immediately after the sequencing of the human genome, there was much hope that tremendous progress in pharmacogenomics woul...
Autores principales: | Licinio, Julio, Wong, Ma-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181965/ https://www.ncbi.nlm.nih.gov/pubmed/21485747 |
Ejemplares similares
-
Pharmacogenomic strategy for individualizing antidepressant therapy
por: Lin, Keh-Ming, et al.
Publicado: (2008) -
Pharmacogenomics in depression and antidepressants
por: Bondy, Brigitta
Publicado: (2005) -
Translating Pharmacogenomics: Challenges on the Road to the Clinic
por: Swen, Jesse J, et al.
Publicado: (2007) -
Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments
por: Lin, Eugene, et al.
Publicado: (2021) -
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
por: Correia, Catarina, et al.
Publicado: (2022)